Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex

Cytometry

Volumn 41, Issue 4, 2000, Pages 321-328

  Hoffmann, Thomas K ^a   Donnenberg, Vera S ^a,b   Friebe Hoffmann, Ulrike ^d   Michael Meyer, E ^a,b   Rinaldo, Charles R ^a,c   Deleo, Albert B ^a,d   Whiteside, Theresa L ^a,b   Donnenberg, Albert D ^a,b,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

CD3; Human immunodeficiency virus; Influenza virus; MHC class I tetramer

Indexed keywords

ANTIBODY; CD14 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR; TETRAMER;

ACCURACY; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MODEL; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR AFFINITY; RECEPTOR BINDING; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN INFLUENZA VIRUS; INFLUENZA VIRUS; RNA VIRUSES;

EID: 0034544834     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0320(20001201)41:4<321::AID-CYTO11>3.0.CO;2-9     Document Type: Article

References (27)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. Ligand recognition by alpha beta T cell receptors
3. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
4. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
5. Quantification of HW-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
6. Ex vivo staining of metastatic lymph nodes by class I major hlstocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
7. Frequency of class I HLA-restricted anti-HW CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)
8. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers
9. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
10. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1 infected patients with advanced immunodeficiency
11. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens
12. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent
13. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding
14. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
15. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
16. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy
17. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression
18. A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia
19. An antigen-targeted approach to adoptive transfer therapy of cancer
20. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376
21. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
22. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor therapy
23. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations
24. Principles of rare event analysis by flow cytometry: Detection of injected dendritic cells in draining lymphatic tissue
25. Analysing antibody response based on data obtained from serial dilution methods
26. Analysis of successful immune responses in persons infected with hepatitis C virus